REQUEST A DEMO
Total
USD $0.00
Search more companies

Veta Pharma AD (Bulgaria)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Veta Pharma AD Profile Updated: September 08, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Veta Pharma AD is based in Bulgaria. The head office is in Veliko Tarnovo. It operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on 2017. The total number of employees is currently 54 (2023). In its most recent financial highlights, the company reported a net sales revenue drop of 3.42% in 2022. A negative growth of 2.23% was recorded in its total assets. In, 2022, the company’s net profit margin decreased by 2.09%.

Headquarters
32 Dalga Laka Str.
Veliko Tarnovo; Veliko Tarnovo; Postal Code: 5000

Contact Details: Purchase the Veta Pharma AD report to view the information.

Basic Information
Total Employees:
Purchase the Veta Pharma AD report to view the information.
Outstanding Shares:
Purchase the Veta Pharma AD report to view the information.
Registered Capital:
Purchase the Veta Pharma AD report to view the information.
Incorporation Date:
2017
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Company Performance
Financial values in the chart are available after Veta Pharma AD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
-3.42%
Total operating revenue
-1.48%
Net Profit (Loss) for the Period
-27.39%
Total assets
-2.23%
Total equity
-1.02%
Net Profit Margin
-2.09%
Return on Equity (ROE)
-1.59%
Quick Ratio
3.91%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?